David Greenhalgh

Chief of Burns

Shriners Hospitals for Children Northern California
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Greenhalgh serves as the Chief of Burns at Shriners Hospitals for Children Northern California. His research focuses on burn care management, including outpatient follow-up and innovative treatments for burn injuries. He has contributed significantly to the understanding of burn injury severity and the metabolic impacts of biodegradable temporizing matrix in burn patients. Dr. Greenhalgh's expertise is reflected in several recent articles addressing both clinical practice guidelines and specific treatment modalities for burn injuries.

Articles (12)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Intensive care for massively burn patients has increased survival and highlights the need for a solution to the problem of insufficient donor sites for autologous skin coverage. In this case series, we present 10 patients with average burn size of 81% TBSA and mean age of 24 years old, who underwent burn excision followed by either immediate or delayed biodegradable temporizing matrix (BTM) placement. After an integration period, the BTM was delaminated either the day before or immediately prior to placement of cultured epithelial autografts over a widely meshed (4:1 or 6:1) split thickness skin graft. One patient had cultured epithelial autografts alone, without split thickness skin graft, placed on integrated BTM and had successful take. Seven patients survived to discharge and had average 95% wound closure at 135 ± 35 days. The patients had on average 10.4 total operations and 8.7 excision and grafting operations. Five patients had complications related to the BTM requiring removal or replacement including three fungal infections, one bacterial infection and one with bleeding and a large clot burden. In conclusion, this surgical strategy is a viable option for patients with massive burns and insufficient donor for autologous skin grafting.

Year:

2023

Year:

2023

Year:

2023

Collaborators (3)

Jason Heard

Assistant Professor of Surgery

university of california davis medical center

UNITED STATES
View details

Laura S Johnson

Emory University

UNITED STATES
View details

Kathleen Romanowski

University of California, Davis

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.